Ligand Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. 

CEO
Todd Christopher Davis
CEOTodd Christopher Davis
Employees
68
Employees68
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
68
Employees68

LGND Key Statistics

Market cap
3.71B
Market cap3.71B
Price-Earnings ratio
92.91
Price-Earnings ratio92.91
Dividend yield
Dividend yield
Average volume
223.79K
Average volume223.79K
High today
$194.90
High today$194.90
Low today
$187.87
Low today$187.87
Open price
$192.75
Open price$192.75
Volume
193.09K
Volume193.09K
52 Week high
$212.49
52 Week high$212.49
52 Week low
$93.58
52 Week low$93.58

Stock Snapshot

With a market cap of 3.71B, Ligand Pharmaceuticals(LGND) trades at $188.50. The stock has a price-to-earnings ratio of 92.91.

During the trading session on 2025-12-04, Ligand Pharmaceuticals(LGND) shares reached a daily high of $194.90 and a low of $187.87. At a current price of $188.50, the stock is +0.3% higher than the low and still -3.3% under the high.

Trading volume for Ligand Pharmaceuticals(LGND) stock has reached 193.09K, versus its average volume of 223.79K.

Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $212.49 and a low of $93.58.

Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $212.49 and a low of $93.58.

LGND News

Simply Wall St 4d
Will Lower Short Interest Reshape Ligand Pharmaceuticals' Sentiment Among Industry Peers?

Ligand Pharmaceuticals recently reported a 7.23% decline in short interest, with 1.11 million shares now sold short, representing 6.8% of its float, according t...

Will Lower Short Interest Reshape Ligand Pharmaceuticals' Sentiment Among Industry Peers?

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.